Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A01N-065/00
A61K-036/539
A61K-031/35
A61K-036/11
A61K-036/15
A61K-036/185
A61K-036/28
A61K-036/47
A61K-036/48
A61K-036/484
A61K-036/486
A61K-036/53
A61K-036/54
A61K-036/60
A61K-036/906
A61K-036/9062
출원번호
US-0078053
(2013-11-12)
등록번호
US-9370544
(2016-06-21)
발명자
/ 주소
Jia, Qi
출원인 / 주소
Unigen, Inc.
대리인 / 주소
Seed IP Law Group PLLC
인용정보
피인용 횟수 :
0인용 특허 :
84
초록▼
The present invention provides a novel composition of matter comprised of a mixture of two specific classes of compounds—Free-B-ring flavonoids and flavans—for use in the prevention and treatment of diseases and conditions mediated by the COX-2 and 5-LO pathways. The present invention further provid
The present invention provides a novel composition of matter comprised of a mixture of two specific classes of compounds—Free-B-ring flavonoids and flavans—for use in the prevention and treatment of diseases and conditions mediated by the COX-2 and 5-LO pathways. The present invention further provides a novel method for simultaneously inhibiting the cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LO) enzymes, and reducing cox-2 mRNA production. Finally, the present invention includes a method for weight loss and blood glucose control. The methods of this invention are comprised of administering to a host in need thereof an effective amount of the composition of this invention together with a pharmaceutically acceptable carrier. This invention relates generally to the prevention and treatment of diseases and conditions mediated by the cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LO) pathways, including but not limited to the relief joint discomfort and pain associated with conditions such as osteoarthritis, rheumatoid arthritis, and other injuries that result from overuse.
대표청구항▼
1. A capsule, tablet, pill, or microcapsule formulation for alleviating joint pain and/or joint stiffness in a human consisting essentially of a therapeutically effective amount of a combination of a Scutellaria extract, an Acacia extract, and a component selected from the group consisting of silica
1. A capsule, tablet, pill, or microcapsule formulation for alleviating joint pain and/or joint stiffness in a human consisting essentially of a therapeutically effective amount of a combination of a Scutellaria extract, an Acacia extract, and a component selected from the group consisting of silica, boron, glucosamine sulfate, chondroitin sulfate, carboxymethylcellulose, copper gluconate, dextrose, saline, vitamin D, shark cartilage and bovine cartilage. 2. The formulation of claim 1, wherein the Scutellaria extract is a partially purified Scutellaria extract enriched for Free-B-ring flavonoids containing baicalin. 3. The formulation of claim 1, wherein the Acacia extract is a partially purified Acacia extract enriched for flavans containing catechin, epicatechin or both. 4. The formulation of claim 1, wherein the Scutellaria extract is a partially purified Scutellaria extract enriched for Free-B-ring flavonoids containing baicalin, and the Acacia extract is a partially purified Acacia extract enriched for flavans containing catechin, epicatechin or both. 5. The formulation of claim 1, wherein the Scutellaria extract is from a Scutellaria plant species selected from Scutellaria baicalensis, Scutellaria orthocalyx, or both. 6. The formulation of claim 1, wherein the Acacia extract is from an Acacia plant species selected from Acacia catechu, Acacia concinna, Acacia farnesiana, Acacia Senegal, Acacia speciosa, Acacia arabica, Acacia caesia, Acacia pennata, Acacia sinuata, Acacia mearnsii, Acacia picnantha, Acacia dealbata, Acacia auriculiformis, Acacia holoserecia, Acacia mangium, or a combination thereof. 7. The formulation of claim 1, wherein the Scutellaria extract is from Scutellaria baicalensis and the Acacia extract is from Acacia catechu. 8. The formulation of claim 1, wherein the partially purified Scutellaria extract enriched for Free-B-ring flavonoids is from Scutellaria baicalensis and the partially purified Acacia extract enriched for flavans is from Acacia catechu. 9. The formulation of claim 1, wherein the Scutellaria extract and the Acacia extract are each from a plant part selected from the group consisting of stems, stem barks, trunks, trunk barks, twigs, tubers, roots, root barks, young shoots, seeds, rhizomes, flowers, leaves, and any combination thereof. 10. The formulation of claim 4, wherein the ratio of Free-B-ring flavonoids to flavans in the formulation ranges from about 90:10 to about 10:90. 11. The formulation of claim 8, wherein the ratio of Free-B-ring flavonoids to flavans in the formulation ranges from about 90:10 to about 10:90. 12. The formulation of claim 4, wherein the ratio of Free-B-ring flavonoids to flavans in the formulation ranges from about 85:15 to about 20:80. 13. The formulation of claim 4, wherein the ratio of Free-B-ring flavonoid to flavans in the formulation is about 85:15. 14. The formulation of claim 4, wherein at least 80% of the total weight of the formulation is Free-B-ring flavonoids and flavans. 15. The formulation of claim 4, wherein the Free-B-ring flavonoids are major active components of the formulation. 16. The formulation of claim 4, wherein the flavans are major active components of the formulation. 17. The formulation of claim 4, wherein the Free-B-ring flavonoids and the flavans are major active components of the formulation. 18. The formulation of claim 8, wherein the Free-B-ring flavonoids and the flavans are major active components of the formulation. 19. The formulation of claim 4, wherein baicalin, catechin or both are major active ingredients of the formulation. 20. The formulation of claim 4, wherein the formulation is a capsule.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (84)
Thomas Newmark ; Paul Schulick, Anti-Inflammatory herbal composition and method of use.
Woo, Sung-Sick; Jo, Tae Hyung; Kim, Dong Seon; Sung, Sun-Young; Do, Seon-Gil; Lee, Young Chul; Nam, Jeong Bum; Ryu, Jong Ha; Lee, Kang Woo; Sung, Hee Sun; Heo, Young Moon; Oh, Mi-Sun; Cho, Ji Nyeo; Sung, Sookyoung; Lee, Ju Yeon; Kim, Tae Woo; Song, Ji Sook; Lee, Seoung Ho; Kim, Mi Ran, Composition comprising bamboo extract and the compounds isolated therefrom showing treating and preventing activity for inflammatory and blood circulation disease.
Blank Robert G. (Hammonton NJ) Mody Dhiraj S. (Hammonton NJ) Kenny Richard J. (Manahawkin NJ) Aveson Martha C. (Voorhees NJ), Fast dissolving dosage forms.
Jia, Qi; Burnett, Bruce; Zhao, Yuan, Formulation of a mixture of Free-B-Ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments.
Jia, Qi; Burnett, Bruce; Zhao, Yuan, Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments.
Jia, Qi; Burnett, Bruce; Zhao, Yuan, Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments.
Nair Muraleedharan G. ; Wang Haibo ; Strasburg Gale M. ; Booren Alden M. ; Gray James I., Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids.
Kang Kwon J. (101-5 Nonhyun-Dong ; Kangnam-Ku Seoul KRX), Method of administrating a fused salt from natural substances, namely ginkgo, persimmon, pine, and bamboo in the treatme.
Ochoa Augusto C. (St. Paul MN) Bach Fritz H. (Minneapolis MN) Alter Barbara (Marine on St. Croix MN) Sondel Paul (Madison WI), Method of culturing lymphocytes and method of treatment using such lymphocytes.
Walker Edward B. (Ogden UT) Mickelsen ; Jr. Richard A. (Ogden UT) Mickelsen Jennifer N. (Ogden UT), Method of treating or preventing non-viral microbial infection.
Niebes Paul J. (Grez Doiceau BEX) Vincze Andras B. (Brussels BEX) Roba Joseph L. (Ciernont-Houyet BEX) Lambelin Georges E. (Brussels BEX) Matagne Daniel M. (Taviers BEX) Hanon Etienne T. (Brussels BE, Pharmaceutical composition and therapeutical method for treating degenerative affections of the articular cartilage.
Han Young-Bok,KRX ; Hong Eun-Kyung,KRX ; Chung Young-Shin,KRX ; Kim Sung-Jin,KRX ; Lee Kyung-Yung,KRX ; Shin Young-Lok,KRX, Pharmaceutical composition comprising an aqueous extract of a mixture of anemarrhena rhizoma and phellodedron bark for analgesic and anti-inflammation.
Han Young Bok,KRX ; Hong Eun Kyung,KRX ; Chung Young Shin,KRX ; Yoo Bo Im,KRX ; Kim Sang Geon,KRX ; Lee Kyung Yung,KRX, Pharmaceutical composition containing a mixed extract of Phellodendron amurense RUPRECHT cortex and Patrinia scabiosaefolia FISCH. for treatment of hepatitis C.
Singh Amarjit,INX ; Jain Rajesh,INX ; Singla Anil Kumar,INX, Pharmaceutical composition for the control and treatment of anorectal and colonic diseases.
Armah George Enyimah,GHX ; Achel Daniel Gyingiri,GHX ; Acquaah ; deceased Robert Asare,GHX ITX by Elizabeth Acquaah ; executor ; Belew Makonnen,SEX, Purification of miraculin glycoprotein using tandem hydrophobic interaction chromatography.
Bath Teresa K. ; Lynch Neal, Therapeutic compositions containing glucosamine, collagen and a bioflavanol for repair and maintenance of connective tissue.
Van Scott Eugene J. (1138 Sewell Lane Rydal PA 19046) Yu Ruey J. (4400 Dexter St. Philadelphia PA 19128), Treatment of acne utilizing N-methyldiethanolamine.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.